Table 2.

Pairwise Comparisons by Treatment Group at 6 Months^a

	Established vs. Advice Only Mean (95% CI)	P-Value	Established + DASH vs. Advice Only Mean (95% CI)	P-Value	Established + DASH vs. Established Mean (95% CI)	P-Value
LDL Cholesterol (mg/dL)
All	−5.6 (−9.0 to −2.2)	.001	−4.0 (002D7.6 to −0.4)	.03	1.6 (−2.0 to 5.2)	.39
LDL ≥ 130 mg/dL	−8.9 (−14.0 to −3.8)	.001	−8.4 (−13.6 to −3.3)	.001	0.5 (−4.7 to 5.7)	.85
LDL < 130 mg/dL	−2.1 (−6.5 to 2.4)	.37	1.7 (−3.0 to 6.4)	.49	3.7 (−1.0 to 8.5)	.12
HDL Cholesterol (mg/dL)
All	1.0 (−0.0 to 2.1)	.06	−0.3 (−1.3 to 0.8)	.58	−1.3 (−2.4 to −0.2)	.02
HDL ≥ 40 mg/dL (Male) and 50 mg/dL (Female)	1.3 (−0.4 to 2.9)	.13	−0.8 (−2.4 to 0.8)	.34	−2.1 (−3.9 to −0.3)	.02
HDL < 40 mg/dL (Male) and 50 mg/dL (Female)	0.7 (−0.6 to 1.9)	.32	0.3 (−1.0 to 1.6)	.68	−0.4 (−1.7 to 0.9)	.57
Triglycerides (mg/dL)
All	−19.7 (−30.6 to −8.8)	<.001	−5.3 (−18.3 to 7.6)	.42	14.4 (2.7 to 26.0)	.02
Triglyceride ≥ 200 mg/dL	−71.0 (−120.4 to −21.7)	.005	−23.2 (−82.3 to 35.9)	.44	47.9 (−0.5 to 96.2)	.05
Triglyceride < 200 mg/dL	−9.2 (−17.2 to −1.2)	.02	−2.7 (−10.7 to 5.3)	.51	6.5 (−1.4 to 14.5)	.11
Total Cholesterol (mg/dL)
All	−7.3 (−11.1 to −3.5)	<.001	−5.7 (−9.7 to −1.7)	.006	1.6 (−2.6 to 5.8)	.45
Total Cholesterol ≥ 240 mg/dL	−17.5 (−27.9 to −7.0)	.001	−19.1 (−30.6 to −7.6)	.001	−1.7 (−13.1 to 9.7)	.77
Total Cholesterol < 240 mg/dL	−5.0 (−9.1 to −0.9)	.02	−2.4 (−6.4 to 1.7)	.26	2.6 (−1.6 to 6.9)	.23

^aData are presented as mean difference (95% Confidence Interval) unless otherwise indicated